News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,340 Results
Type
Article (38705)
Company Profile (246)
Press Release (638389)
Section
Business (203346)
Career Advice (1974)
Deals (35343)
Drug Delivery (77)
Drug Development (80527)
Employer Resources (167)
FDA (15976)
Job Trends (14772)
News (343367)
Policy (32402)
Tag
Academia (2528)
Africa (710)
Alliances (48921)
Alzheimer's disease (1132)
Approvals (15922)
Arizona (169)
Artificial intelligence (64)
Asia (36698)
Australia (5967)
Bankruptcy (350)
Best Places to Work (11209)
Biosimilars (60)
Biotechnology (170)
C2C Services and Suppliers (78803)
California (1520)
Canada (829)
Cancer (319)
Career advice (1644)
Cell therapy (96)
China (109)
Clinical research (62886)
Collaboration (105)
Colorado (63)
Connecticut (59)
COVID-19 (2471)
Cystic fibrosis (71)
Data (124)
Diabetes (64)
Diagnostics (5940)
Drug pricing (59)
Earnings (83608)
Employer resources (140)
Europe (78378)
Events (107308)
Executive appointments (86)
FDA (16140)
Florida (207)
Funding (91)
Gene therapy (73)
GLP-1 (497)
Government (4282)
Healthcare (18569)
Hotbed/Location (480974)
Idaho (56)
Illinois (230)
Indiana (133)
Infectious disease (2495)
Inflammatory bowel disease (86)
Interviews (305)
IPO (16162)
Job creations (3618)
Job search strategy (1411)
Kansas (93)
Layoffs (388)
Legal (7827)
Lung cancer (69)
Manufacturing (71)
Maryland (336)
Massachusetts (1272)
Medical device (13012)
Medtech (13015)
Mergers & acquisitions (18985)
Metabolic disorders (213)
Michigan (114)
Minnesota (201)
Neuroscience (1241)
New Jersey (468)
New York (476)
NextGen Class of 2024 (6477)
Non-profit (4452)
North Carolina (554)
Northern California (693)
Obesity (132)
Ohio (96)
Opinion (167)
Patents (55)
Pennsylvania (511)
People (55683)
Pharmaceutical (59)
Phase I (19478)
Phase II (27698)
Phase III (20701)
Pipeline (91)
Postmarket research (2545)
Preclinical (8290)
Press Release (64)
Rare diseases (111)
Real estate (5878)
Recruiting (63)
Regulatory (21128)
Research institute (2300)
Resumes & cover letters (345)
South America (1084)
Southern California (624)
Startups (3554)
Texas (179)
United States (7260)
Vaccines (443)
Washington State (232)
Weight loss (116)
Date
Last 7 days (461)
Last 30 days (2176)
Last 365 days (37407)
2024 (24436)
2023 (40075)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46542)
2018 (35020)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
677,340 Results for "cytosorbents inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
CytoSorbents Corporation announces the regulatory approval of CytoSorb® in Taiwan by the Taiwan Food and Drug Administration (TFDA).
June 24, 2024
·
6 min read
Pharm Country
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
CytoSorbents Corporation announces that it will host its 2024 Virtual Annual Stockholders Meeting tomorrow, June 6, 2024 at 10 AM EDT.
June 5, 2024
·
5 min read
Pharm Country
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
CytoSorbents Corporation announces the launch and immediate availability of its PuriFi™ hemoperfusion machine in the E.U., following approval and certification under the E.U. Medical Device Regulation.
June 13, 2024
·
7 min read
Business
CytoSorbents Reports First Quarter 2024 Results
CytoSorbents Corporation (NASDAQ: CTSO), a pioneer in critical care and cardiac surgery blood purification technologies, today reported unaudited financial and operating results for the quarter ended March 31, 2024.
May 9, 2024
·
16 min read
Pharm Country
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
CytoSorbents Corporation announces the recent data presentation entitled “Early CABG with Intraoperative Haemoadsorption in Patients on Ticagrelor: The Safe and Timely Antithrombotic Removal Registry,” at the international EuroPCR 2024 conference in Paris, France - the world-leading course in interventional cardiovascular medicine with over 12,000 attendees - where it was also selected as a top 5 finalist in the best scientific abstract competition.
June 4, 2024
·
9 min read
Press Releases
CytoSorbents Secures $20 Million Credit Facility
July 2, 2024
·
8 min read
Business
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
CytoSorbents Corporation, a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report fiscal 2023 financial results on Thursday, March 14th, 2024 at 4:30PM EDT.
March 6, 2024
·
5 min read
Business
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported financial and operating results for the quarter and year ended December 31, 2023 and provides its 2024 outlook.
March 14, 2024
·
28 min read
Pharm Country
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
CytoSorbents Corporation announced that it will host a virtual Key Opinion Leader and Analyst-Investor Day on Monday, May 6, 2024 from 11:30 AM to 1:30 PM ET.
May 2, 2024
·
10 min read
Pharm Country
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
CytoSorbents Corporation announces that Dr. Phillip Chan, Chief Executive Officer, will present at the TD Cowen 44th Annual Health Care Conference at the Boston Marriott Copley Place, in Boston, MA on Wednesday, March 6th, 2024.
February 8, 2024
·
5 min read
1 of 67,734
Next